Amdocs Financial Statements From 2010 to 2024

DOX Stock  USD 89.90  0.52  0.58%   
Amdocs financial statements provide useful quarterly and yearly information to potential Amdocs investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Amdocs financial statements helps investors assess Amdocs' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Amdocs' valuation are summarized below:
Gross Profit
1.6 B
Profit Margin
0.113
Market Capitalization
10.5 B
Enterprise Value Revenue
2.1573
Revenue
4.9 B
We have found one hundred twenty available fundamental signals for Amdocs, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Amdocs prevailing market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road.
Check Amdocs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amdocs main balance sheet or income statement drivers, such as Depreciation And Amortization of 181.9 M, Interest Expense of 21.3 M or Total Revenue of 3.1 B, as well as many exotic indicators such as Short Term Coverage Ratios of 39.96, Price Earnings Ratio of 20.09 or Price To Sales Ratio of 3.4. Amdocs financial statements analysis is a perfect complement when working with Amdocs Valuation or Volatility modules.
  
This module can also supplement Amdocs' financial leverage analysis and stock options assessment as well as various Amdocs Technical models . Check out the analysis of Amdocs Correlation against competitors.
For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.

Amdocs Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets4.5 B7.4 B5.3 B
Slightly volatile
Short and Long Term Debt Total974.8 M928.4 M639.7 M
Slightly volatile
Total Current LiabilitiesB1.6 B1.2 B
Slightly volatile
Total Stockholder Equity2.8 B4.1 B3.2 B
Slightly volatile
Property Plant And Equipment Net1.1 B1.1 B592.8 M
Slightly volatile
Accounts Payable428.4 M337.3 M579.9 M
Slightly volatile
Cash720.1 M598.1 M699.9 M
Pretty Stable
Non Current Assets Total2.6 B5.2 B3.3 B
Slightly volatile
Non Currrent Assets Other762.6 M726.3 M475.7 M
Slightly volatile
Cash And Short Term InvestmentsB853.9 M915.9 M
Very volatile
Net Receivables618.6 M1.1 B788.5 M
Slightly volatile
Common Stock Shares Outstanding144.3 M107 M145.4 M
Slightly volatile
Liabilities And Stockholders Equity4.5 B7.4 B5.3 B
Slightly volatile
Non Current Liabilities Total1.8 B1.7 B940.4 M
Slightly volatile
Other Current Assets307 M258.3 M191.8 M
Slightly volatile
Total Liabilities1.7 B3.3 BB
Slightly volatile
Total Current Assets1.9 B2.2 B1.9 B
Pretty Stable
Common Stock Total Equity4.3 M5.2 M4.3 M
Slightly volatile
Property Plant And Equipment Gross1.1 B1.1 B594 M
Slightly volatile
Common Stock4.4 M5.3 M4.4 M
Slightly volatile
Current Deferred Revenue184.3 M196.2 M164.2 M
Slightly volatile
Other Liabilities469.4 M913 M584.8 M
Slightly volatile
Other Assets386.6 M661.2 M440.4 M
Slightly volatile
Long Term Debt779.7 M742.6 M447 M
Slightly volatile
Good Will1.9 B3.2 B2.2 B
Slightly volatile
Intangible Assets317.6 M163.4 M271.2 M
Slightly volatile
Property Plant Equipment1.2 B1.1 B561.7 M
Slightly volatile
Net Tangible Assets676.1 M609 M895.7 M
Slightly volatile
Deferred Long Term Liabilities212.7 M197.5 M248.2 M
Slightly volatile
Short and Long Term Debt146.1 M90 M146.6 M
Slightly volatile
Capital Surpluse3.8 B4.2 B3.5 B
Slightly volatile
Non Current Liabilities Other568.9 M848.7 M465.2 M
Slightly volatile
Net Invested Capital4.3 B4.8 B3.9 B
Slightly volatile
Net Working Capital537.1 M502.4 M732.8 M
Slightly volatile
Capital StockM5.3 M4.6 M
Slightly volatile
Capital Lease Obligations173.8 M145.5 M252.7 M
Slightly volatile

Amdocs Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization181.9 M225.1 M181.4 M
Slightly volatile
Total Revenue3.1 B5.6 B3.8 B
Slightly volatile
Gross Profit1.1 BB1.3 B
Slightly volatile
Other Operating Expenses2.7 B4.8 B3.2 B
Slightly volatile
Operating Income403.8 M752.1 M495.4 M
Slightly volatile
EBIT431.2 M833.6 M522.3 M
Slightly volatile
Research Development221.8 M431.1 M270.1 M
Slightly volatile
EBITDA613.1 M1.1 B703.6 M
Slightly volatile
Cost Of RevenueB3.6 B2.4 B
Slightly volatile
Total Operating Expenses684 M1.2 B793.3 M
Slightly volatile
Income Before Tax423 M731.8 M517.9 M
Slightly volatile
Net Income350.4 M621.8 M440.4 M
Slightly volatile
Income Tax Expense72.5 M107.4 M77.1 M
Slightly volatile
Selling General Administrative390.6 M656.3 M452.2 M
Slightly volatile
Net Income Applicable To Common Shares396.4 M631.9 M444.5 M
Slightly volatile
Net Income From Continuing Ops531 M624.4 M483.2 M
Slightly volatile
Non Recurring10.4 M11.7 M12.7 M
Slightly volatile
Tax Provision95.1 M107.4 M83.3 M
Slightly volatile
Interest Income25.7 M24.4 M9.9 M
Slightly volatile
Reconciled Depreciation166.8 M176.1 M206.1 M
Slightly volatile

Amdocs Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow699.6 M659.4 M720.9 M
Very volatile
Depreciation181.9 M225.1 M181.4 M
Slightly volatile
Dividends Paid170.3 M229.4 M134.5 M
Slightly volatile
Capital Expenditures123.3 M143 M144.4 M
Slightly volatile
Total Cash From Operating Activities560.9 M946 M655.5 M
Slightly volatile
Net Income350.6 M624.4 M440.8 M
Slightly volatile
End Period Cash Flow721.1 M598.1 M701.5 M
Pretty Stable

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price Earnings Ratio20.0921.1448.4414
Slightly volatile
Price To Sales Ratio3.42.342.7123
Slightly volatile
Dividend Yield0.03780.02310.017
Slightly volatile
Operating Cycle44.1863.4880.8536
Slightly volatile
Price Book Value Ratio1.382.544.1499
Slightly volatile
Days Of Payables Outstanding60.230.588.9522
Slightly volatile
Operating Cash Flow Per Share6.616.294.8264
Slightly volatile
Dividend Payout Ratio0.40.420.4831
Slightly volatile
Price To Operating Cash Flows Ratio19.9213.919.1605
Slightly volatile
Pretax Profit Margin0.110.120.1318
Pretty Stable
Ebt Per Ebit0.830.881.0137
Pretty Stable
Payables Turnover6.289.697.6213
Slightly volatile
Operating Profit Margin0.150.13380.1379
Pretty Stable
Effective Tax Rate0.30.170.197
Pretty Stable
Company Equity Multiplier1.021.641.6274
Pretty Stable
Cash Per Share4.375.686.1419
Very volatile
Return On Capital Employed0.140.150.1452
Slightly volatile
Payout Ratio0.40.420.4831
Slightly volatile
Ebit Per Revenue0.150.13380.1379
Pretty Stable
Quick Ratio1.791.431.4791
Pretty Stable
Net Income Per E B T0.580.760.7901
Pretty Stable
Cash Ratio0.790.440.6165
Slightly volatile
Operating Cash Flow Sales Ratio0.210.190.1732
Slightly volatile
Days Of Sales Outstanding58.5463.4875.5565
Slightly volatile
Price To Book Ratio1.382.544.1499
Slightly volatile
Current Ratio2.011.621.6747
Pretty Stable
Fixed Asset Turnover10.295.98.7538
Slightly volatile
Price Cash Flow Ratio19.9213.919.1605
Slightly volatile
Enterprise Value Multiple14.4512.7812.582
Pretty Stable
Price Sales Ratio3.42.342.7123
Slightly volatile
Return On Assets0.06260.07570.0779
Pretty Stable
Receivables Turnover5.645.954.8597
Slightly volatile
Asset Turnover0.840.870.7675
Pretty Stable
Net Profit Margin0.080.09960.1083
Pretty Stable
Gross Profit Margin0.410.35350.3632
Pretty Stable
Price Fair Value1.382.544.1499
Slightly volatile
Return On Equity0.06950.140.1268
Slightly volatile

Amdocs Fundamental Market Drivers

Forward Price Earnings13.7741
Cash And Short Term Investments742.5 M

Amdocs Upcoming Events

6th of February 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
5th of November 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of September 2023
Last Financial Announcement
View

About Amdocs Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Amdocs income statement, its balance sheet, and the statement of cash flows. Amdocs investors use historical funamental indicators, such as Amdocs's revenue or net income, to determine how well the company is positioned to perform in the future. Although Amdocs investors may use each financial statement separately, they are all related. The changes in Amdocs's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Amdocs's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Amdocs Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Amdocs. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Current Deferred Revenue196.2 M184.3 M
Total Revenue5.6 B3.1 B
Cost Of Revenue3.6 BB
Ebit Per Revenue 0.13  0.15 

Pair Trading with Amdocs

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amdocs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amdocs will appreciate offsetting losses from the drop in the long position's value.

Moving against Amdocs Stock

  0.75AVPTW AvePointPairCorr
  0.66EGIO Edgio Inc Tech BoostPairCorr
The ability to find closely correlated positions to Amdocs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amdocs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amdocs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amdocs to buy it.
The correlation of Amdocs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amdocs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amdocs moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amdocs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Amdocs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amdocs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amdocs Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amdocs Stock:
Check out the analysis of Amdocs Correlation against competitors.
For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Complementary Tools for Amdocs Stock analysis

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.18
Dividend Share
1.74
Earnings Share
4.68
Revenue Per Share
41.665
Quarterly Revenue Growth
0.05
The market value of Amdocs is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amdocs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.